OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

What is the purpose of this trial?

To evaluate in a randomized controlled trial the efficacy of surfactant delivery via a minimally invasive technique in preterm infants 25-28 weeks gestation with respiratory distress syndrome (RDS) treated with NCPAP/NIPPV.

Gender: Both

Menzies Research Institute, Tasmania

Start Date: 01/02/2015

End Date: 03/01/2016

Last Updated: 02/22/2018

Study HIC#: 1403013562

Get Involved

For more information about this study, contact:
Christine H Mulvey
+1 203-688-2320

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image


Richard Allan Ehrenkranz

Principal Investigator